Literature DB >> 22722329

New classes of carborane-appended 5-thio-D-glucopyranose derivatives.

Rashmirekha Satapathy1, Barada Prasanna Dash, Barrie P Bode, Emily A Byczynski, Sumathy N Hosmane, Sajit Bux, Narayan S Hosmane.   

Abstract

A series of carborane-appended 5-thio-D-glucopyranose (5-TDGP) derivatives containing one to two 5-TDGP moieties were synthesized via click cycloaddition reaction as well as following the traditional methods. Among the carboranyl-5-TDGP derivatives, the decapitated nido-carboranyl derivative 18 was found to be highly water-soluble and therefore its preliminary biodistribution study was conducted. A comparative biological evaluation of 18 versus its carboranyl-D-glucopyranose analog 19 with human hepatocellular carcinoma cells (SK-Hep1) indicated 5-TDGP to be a better boron carrier than normal D-glucopyranose. The carboranyl-5-TDGP 18 showed a nearly two fold increase in cellular boron accumulation than carboranyl-D-glucopyranose analog 19 over a period of 2 h. The accumulation of both 18 and 19 was found to occur in a temperature dependent manner. The higher accumulation of 18 suggested excellent promise for it to be a candidate for further evaluation as a future BNCT agent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722329     DOI: 10.1039/c2dt30874f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

Review 1.  Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.

Authors:  Micah John Luderer; Pilar de la Puente; Abdel Kareem Azab
Journal:  Pharm Res       Date:  2015-06-02       Impact factor: 4.200

2.  Preparation of dendritic carboranyl glycoconjugates as potential anticancer therapeutics.

Authors:  Biswa Ranjan Swain; Chandra Sekhara Mahanta; Bibhuti Bhusan Jena; Swaraj Kumar Beriha; Bismita Nayak; Rashmirekha Satapathy; Barada P Dash
Journal:  RSC Adv       Date:  2020-09-18       Impact factor: 4.036

3.  Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to In Vitro Assessment.

Authors:  Jelena Matović; Juulia Järvinen; Helena C Bland; Iris K Sokka; Surachet Imlimthan; Ruth Mateu Ferrando; Kristiina M Huttunen; Juri Timonen; Sirpa Peräniemi; Olli Aitio; Anu J Airaksinen; Mirkka Sarparanta; Mikael P Johansson; Jarkko Rautio; Filip S Ekholm
Journal:  Mol Pharm       Date:  2020-09-02       Impact factor: 4.939

4.  In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.

Authors:  Atsushi Fujimura; Seiji Yasui; Kazuyo Igawa; Ai Ueda; Kaori Watanabe; Tadashi Hanafusa; Yasuaki Ichikawa; Sachiko Yoshihashi; Kazuki Tsuchida; Atsunori Kamiya; Shuichi Furuya
Journal:  Cells       Date:  2020-09-23       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.